JP2021520849A5 - - Google Patents
Info
- Publication number
- JP2021520849A5 JP2021520849A5 JP2021504566A JP2021504566A JP2021520849A5 JP 2021520849 A5 JP2021520849 A5 JP 2021520849A5 JP 2021504566 A JP2021504566 A JP 2021504566A JP 2021504566 A JP2021504566 A JP 2021504566A JP 2021520849 A5 JP2021520849 A5 JP 2021520849A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tumor antigen
- acid sequence
- seq
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024046768A JP2024069663A (ja) | 2018-04-13 | 2024-03-22 | 腫瘍特異的t細胞受容体を得る方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/082947 | 2018-04-13 | ||
| PCT/CN2018/082947 WO2019196088A1 (en) | 2018-04-13 | 2018-04-13 | Methods of obtaining tumor-specific t cell receptors |
| PCT/CN2019/082408 WO2019196924A1 (en) | 2018-04-13 | 2019-04-12 | Methods of obtaining tumor-specific t cell receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024046768A Division JP2024069663A (ja) | 2018-04-13 | 2024-03-22 | 腫瘍特異的t細胞受容体を得る方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021520849A JP2021520849A (ja) | 2021-08-26 |
| JP2021520849A5 true JP2021520849A5 (cg-RX-API-DMAC7.html) | 2022-04-20 |
| JP7549826B2 JP7549826B2 (ja) | 2024-09-12 |
Family
ID=68163041
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504566A Active JP7549826B2 (ja) | 2018-04-13 | 2019-04-12 | 腫瘍特異的t細胞受容体を得る方法 |
| JP2024046768A Pending JP2024069663A (ja) | 2018-04-13 | 2024-03-22 | 腫瘍特異的t細胞受容体を得る方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024046768A Pending JP2024069663A (ja) | 2018-04-13 | 2024-03-22 | 腫瘍特異的t細胞受容体を得る方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US11390659B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3775168A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7549826B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102805266B1 (cg-RX-API-DMAC7.html) |
| CN (4) | CN113185602B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2019196088A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016145578A1 (en) | 2015-03-13 | 2016-09-22 | Syz Cell Therapy Co. | Methods of cancer treatment using activated t cells |
| WO2019183924A1 (en) | 2018-03-30 | 2019-10-03 | Syz Cell Therapy Co. | Improved multiple antigen specific cell therapy methods |
| WO2019196088A1 (en) | 2018-04-13 | 2019-10-17 | Syz Cell Therapy Co. | Methods of obtaining tumor-specific t cell receptors |
| WO2019196087A1 (en) | 2018-04-13 | 2019-10-17 | Syz Cell Therapy Co. | Methods of cancer treatment using tumor antigen-specific t cells |
| CN116298309B (zh) | 2018-08-13 | 2024-04-02 | 根路径基因组学公司 | 成对的二分免疫受体多核苷酸的高通量克隆及其应用 |
| MX2021012207A (es) | 2019-04-05 | 2021-12-10 | Rootpath Genomics Inc | Composiciones y métodos para ensamblaje de genes del receptor de linfocitos t. |
| JP2022535006A (ja) * | 2019-05-31 | 2022-08-04 | モデルナティエックス インコーポレイテッド | 増殖t細胞アッセイ |
| US20210040558A1 (en) * | 2019-07-15 | 2021-02-11 | Neogene Therapeutics B.V. | Method to isolate tcr genes |
| EP4061487A4 (en) * | 2019-11-19 | 2023-12-20 | Rootpath Genomics, Inc. | COMPOSITIONS AND METHODS FOR IDENTIFYING T CELL RECEPTOR |
| US12612444B2 (en) | 2019-11-26 | 2026-04-28 | University of Pittsburgh—of the Commonwealth System of Higher Education | T cell receptors targeting mutations in RNA splicing factors |
| EP4100051A2 (en) * | 2020-02-07 | 2022-12-14 | ISA Pharmaceuticals B.V. | Treatment of hpv-related diseases |
| CN111234005B (zh) * | 2020-03-13 | 2022-11-29 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 氨苯砜药物超敏反应性t细胞受体及其用途 |
| IL301543A (en) * | 2020-09-24 | 2023-05-01 | Medigene Immunotherapies Gmbh | Prame specific t cell receptors and uses thereof |
| JP2024526836A (ja) * | 2021-07-19 | 2024-07-19 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | Fanci、rad51、およびpbk抗原を標的とするペプチドおよび操作されたt細胞受容体ならびに使用の方法 |
| WO2023049733A2 (en) * | 2021-09-21 | 2023-03-30 | The University Of Chicago | Methods and composition using patient-derived autologous neoantigens for treating cancer |
| CN116063511B (zh) * | 2021-09-30 | 2023-10-03 | 北京可瑞生物科技有限公司 | 抗原结合蛋白及其应用 |
| US20250025499A1 (en) * | 2021-11-02 | 2025-01-23 | Fred Hutchinson Cancer Center | T cell immunotherapy for hematologic malignancies having an sf3b1 mutation |
| CN119677842A (zh) * | 2022-03-17 | 2025-03-21 | 科士华(南京)生物技术有限公司 | 人工合成肿瘤浸润淋巴细胞 |
| US20260166144A1 (en) * | 2022-04-07 | 2026-06-18 | Carsgen Life Sciences Co., Ltd. | Chimeric polypeptide and use thereof |
| CN116063458A (zh) * | 2022-04-27 | 2023-05-05 | 恒瑞源正(广州)生物科技有限公司 | Mage-a1特异性t细胞受体及其用途 |
| AU2023269389A1 (en) * | 2022-05-10 | 2024-12-19 | Geneos Therapeutics, Inc. | Individualized cancer epitopes and methods of using the same |
| CN114920824B (zh) * | 2022-05-27 | 2023-12-05 | 重庆医科大学 | Tcr或其抗原结合片段及其应用 |
| EP4739702A1 (en) * | 2023-07-07 | 2026-05-13 | The University Of Hong Kong | Convergent recombination-derived hepatocellular carcinoma-specific tcrs and applications thereof |
| CN117567595B (zh) * | 2024-01-17 | 2024-05-14 | 恒瑞源正(广州)生物科技有限公司 | Mage-a4特异性t细胞受体及其用途 |
| CN120518771A (zh) * | 2024-02-20 | 2025-08-22 | 上海信谱生物医药科技有限公司 | 一种识别kras突变的t细胞受体及其编码序列 |
| WO2025193663A2 (en) * | 2024-03-11 | 2025-09-18 | Affini-T Therapeutics, Inc. | Compositions and methods for treating neoplasia |
| CN119613530B (zh) * | 2024-12-13 | 2025-09-05 | 华中科技大学 | 一种靶向肝癌细胞甲胎蛋白抗原肽与hla-a24复合物的特异性tcr分子、tcr-t细胞及制备与应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| EP1235842A4 (en) | 1999-10-15 | 2003-04-23 | Univ Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| WO2001096584A2 (en) | 2000-06-12 | 2001-12-20 | Akkadix Corporation | Materials and methods for the control of nematodes |
| WO2002000692A2 (en) | 2000-06-28 | 2002-01-03 | Genetics Institute, Llc. | Pd-l2 molecules: pd-1 ligands and uses therefor |
| CN1609197A (zh) * | 2003-10-17 | 2005-04-27 | 上海普泛生物科技有限公司 | 一种用于发现肿瘤特异性抗原和肿瘤特异性抗原决定簇的高产率逆反免疫法 |
| US20090304679A1 (en) * | 2004-05-27 | 2009-12-10 | Weidanz Jon A | Antibodies as T cell receptor mimics, methods of production and uses thereof |
| AU2006249640C1 (en) * | 2005-04-08 | 2016-10-13 | Coimmune, Inc. | Dendritic cell compositions and methods |
| EP1795599A1 (en) * | 2005-12-09 | 2007-06-13 | Schuler, Gerold, Prof. Dr. | Methods for generating antigen-specific effector T cells |
| EP2468763B1 (en) * | 2007-05-31 | 2014-06-18 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| AU2008323853B8 (en) | 2007-11-08 | 2014-07-24 | Beth Israel Deaconess Medical Center | Stimulation of anti-tumor immunity using dendritic cell/tumor cell fusions and anti-CD3/CD28 |
| DK2271767T3 (en) | 2008-04-03 | 2016-08-29 | Cb Biotechnologies Inc | Amplikonredning-multiplex polymerase chain reaction for the amplification of multiple target |
| EP2258719A1 (en) * | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| EP3144673B1 (en) * | 2010-05-06 | 2019-07-10 | Adaptive Biotechnologies Corporation | Monitoring lymphoid neoplasm status using clonotype profiles |
| ES2635335T3 (es) | 2010-09-20 | 2017-10-03 | Biontech Cell & Gene Therapies Gmbh | Receptores de células T específicos de antígeno y epítopos de células T |
| US9187534B2 (en) * | 2011-03-11 | 2015-11-17 | Universite De Geneve | Multi-epitopic vaccine |
| US9345770B2 (en) * | 2011-11-16 | 2016-05-24 | University of Pittsburgh—of the Commonwealth System of Higher Education | Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
| JP6309209B2 (ja) * | 2013-05-31 | 2018-04-11 | 国立研究開発法人国立国際医療研究センター | 血管平滑筋細胞の増殖を抑制する血管内皮細胞の検出方法 |
| CN110511960B (zh) * | 2013-07-15 | 2023-05-23 | 美国卫生和人力服务部 | 抗人乳头瘤病毒16 e6 t细胞受体 |
| CN105452448B (zh) | 2013-07-15 | 2020-07-28 | 美国卫生和人力服务部 | 制备抗人乳头瘤病毒抗原的t细胞的方法 |
| SG11201702191YA (en) | 2014-09-17 | 2017-04-27 | Univ Johns Hopkins | Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells |
| CN104593325A (zh) * | 2014-12-09 | 2015-05-06 | 深圳源正细胞医疗技术有限公司 | 诱导dc成熟并分泌高浓度促炎因子的方法 |
| WO2016145578A1 (en) | 2015-03-13 | 2016-09-22 | Syz Cell Therapy Co. | Methods of cancer treatment using activated t cells |
| DK3271382T3 (da) * | 2015-03-16 | 2020-05-04 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek |
| US20180171294A1 (en) | 2015-03-26 | 2018-06-21 | The Trustees Of The University Of Pennsylvania | In vitro artificial lymph node method for sensitization and expansion of t cells for therapy and epitope mapping |
| GB201604492D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers |
| US20170319638A1 (en) * | 2016-05-06 | 2017-11-09 | Virttu Biologics Limited | Treatment of cancer |
| CN109803674A (zh) * | 2016-06-10 | 2019-05-24 | Io生物技术公司 | Calr和jak2疫苗组合物 |
| US9642906B2 (en) * | 2016-09-16 | 2017-05-09 | Baylor College Of Medicine | Generation of HPV-specific T-cells |
| CN106645677B (zh) * | 2016-11-15 | 2019-08-09 | 恒瑞源正(上海)生物科技有限公司 | 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗 |
| MD3551221T2 (ro) * | 2016-12-08 | 2022-04-30 | Immatics Biotechnologies Gmbh | Noi receptori de celule T și imunoterapie cu utilizarea acestora |
| WO2019183924A1 (en) | 2018-03-30 | 2019-10-03 | Syz Cell Therapy Co. | Improved multiple antigen specific cell therapy methods |
| WO2019196088A1 (en) | 2018-04-13 | 2019-10-17 | Syz Cell Therapy Co. | Methods of obtaining tumor-specific t cell receptors |
| WO2019196087A1 (en) | 2018-04-13 | 2019-10-17 | Syz Cell Therapy Co. | Methods of cancer treatment using tumor antigen-specific t cells |
-
2018
- 2018-04-13 WO PCT/CN2018/082947 patent/WO2019196088A1/en not_active Ceased
-
2019
- 2019-04-12 JP JP2021504566A patent/JP7549826B2/ja active Active
- 2019-04-12 EP EP19785434.2A patent/EP3775168A4/en active Pending
- 2019-04-12 CN CN202110295872.5A patent/CN113185602B/zh active Active
- 2019-04-12 WO PCT/CN2019/082408 patent/WO2019196924A1/en not_active Ceased
- 2019-04-12 CN CN201980025587.2A patent/CN112534045A/zh active Pending
- 2019-04-12 CN CN202110295574.6A patent/CN112979783B/zh active Active
- 2019-04-12 CN CN202310140638.4A patent/CN116003575A/zh active Pending
- 2019-04-12 US US17/047,059 patent/US11390659B2/en active Active
- 2019-04-12 KR KR1020207032466A patent/KR102805266B1/ko active Active
-
2022
- 2022-06-17 US US17/843,920 patent/US20230212253A1/en active Pending
- 2022-06-17 US US17/843,912 patent/US20230023834A1/en active Pending
- 2022-06-17 US US17/843,916 patent/US12358967B2/en active Active
- 2022-06-17 US US17/843,917 patent/US20220403000A1/en active Pending
-
2023
- 2023-10-11 US US18/485,248 patent/US20240052010A1/en active Pending
-
2024
- 2024-03-22 JP JP2024046768A patent/JP2024069663A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zander et al. | CD4+ T cell help is required for the formation of a cytolytic CD8+ T cell subset that protects against chronic infection and cancer | |
| JP2018512380A5 (cg-RX-API-DMAC7.html) | ||
| JP2024041873A5 (cg-RX-API-DMAC7.html) | ||
| CN114072516B (zh) | 经修饰的腺病毒 | |
| KR102629590B1 (ko) | 암을 치료하기 위한 방법 | |
| Lutz | Therapeutic potential of semi-mature dendritic cells for tolerance induction | |
| JP2019531744A5 (cg-RX-API-DMAC7.html) | ||
| JP2024038503A5 (cg-RX-API-DMAC7.html) | ||
| RU2017134270A (ru) | Способы лечения рака с применением активированных t-клеток | |
| JP2016525881A5 (cg-RX-API-DMAC7.html) | ||
| JP2020516238A5 (cg-RX-API-DMAC7.html) | ||
| JP2017524337A5 (cg-RX-API-DMAC7.html) | ||
| Welten et al. | Memory CD 8 T cell inflation vs tissue‐resident memory T cells: Same patrollers, same controllers? | |
| US20230357718A1 (en) | Methods and materials for expanding antigen-specific t cells in culture | |
| JP2022538609A5 (cg-RX-API-DMAC7.html) | ||
| US20180078627A1 (en) | Method for antigen loading of dendritic cells and vaccine | |
| JP2022524882A (ja) | 養子移入療法(Adoptive transfer therapies)におけるTリンパ球及びNK細胞の拡大増殖及び分化のための方法 | |
| JP2024538129A5 (cg-RX-API-DMAC7.html) | ||
| CN111315401A (zh) | 细菌疫苗 | |
| Xu et al. | Peptide-MHC–targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells | |
| JP2022500034A5 (cg-RX-API-DMAC7.html) | ||
| EP1697502A2 (fr) | Methodes d identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations | |
| JP7416629B2 (ja) | 免疫応答を増強するための物質および方法 | |
| CN117050159A (zh) | 靶向滑膜肉瘤syt-ssx融合突变的tcr-t细胞、tcr分子及制备方法和应用 | |
| Reinscheid et al. | Acute and chronic infections drive distinct trajectories in human memory CD4+ T cell formation |